Same asset, new use: management describes redeploying something the company already owns into a materially higher-value
The model's full reasoning — Q1 2016 call → NOWe need to determine if management describes a current redirection of an existing asset to a materially more valuable use, with real activity. The transcript discusses various initiatives: cost savings, working capital, merger with Dow, etc. There is mention of "CRISPR-Cas advanced breeding technology" for corn hybrids, but that's a new technology, not redirecting existing. There is mention of "Leptra" insect protected corn hybrids in Brazil, but that's a new product. There is mention of "Zorvec" fungicide, new product. There is mention of "Solamet paste" and "PV19B" but that's product improvement. There is mention of "probiotics" growth, but that's existing business growth. There is mention of "Nutrition & Health" growth, but that's existing. There is mention of "Industrial Biosciences" pricing gains on new product introductions, but that's new products. There is mention of "Protection Solutions" lower costs, not redirection. There is mention of "Performance Materials" lower demand, not redirection. There is mention of "Agriculture" strong start, but that's existing. There is mention of "working capital" improvements, but that's not redirection of assets. There is mention of "merger with Dow" and "intended separations" but that's future. There is mention of "cost savings" but that's not redirection. There is mention of "LaPorte" shutdown, but that's a closure, not redirection. There is mention of "Vydate" replacement, but that's sourcing. There is mention of "agency based route to market" in Southern U.S., but that's a distribution change, not necessarily a change of purpose of an asset. The question asks: "CURRENTLY PUTTING SOMETHING IT ALREADY OWNS OR ALREADY DOES TO A DIFFERENT AND MATERIALLY MORE VALUABLE USE THAN THE USE IT WAS ORIGINALLY BUILT, BOUGHT, OR INTENDED FOR" - that is a specific phenomenon. The transcript does not seem to describe such a redirection. Management talks about cost savings, new products, but not about taking an existing asset and repurposing it for a more valuable use. There is no mention of converting a plant, re-tasking a platform, etc. The closest might be "probiotics" but that's just growth. Or "Solamet" but that's product improvement. Or "CRISPR" but that's new. So answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
APPS · Q1 2024 → YESThe question is whether management describes currently putting something they already own or do to a different and materially more valuable use, and that this is already happening now. YES Bill Stone describes using the company’s existing on-device technology and installed base of hundreds of millions of devices (already owned and paid for) for a new purpose: alternative app distribution via DT Hub and SingleTap monetization. He states they have launched DT Hub with four U.S. operators and are generating revenue today with incremental higher RPDs from devices engaging with the Hub product, and they are leveraging existing hub capabilities to enable direct distribution outside Apple/Google stores. This is presented as already happening now, with the new use delivering better economics through higher RPD accretion and expanded revenue streams.
PRPH · Q1 2023 → YESThe question is whether management describes currently putting something they already own or do to a different and materially more valuable use, and that this change is already happening now. YES The transcript shows management describing a clear redirection of assets already owned: the manufacturing facility (originally kept solely for Cold-EEZE infrastructure after the brand sale) is now being run for third-party lozenge manufacturing, with revenues growing nearly 100% year-over-year and $25 million targeted for 2024 — a use they explicitly call “the least interesting business” yet one with “enormous value” and an estimated $70 million next-year market value.
GGR · Q1 2023 → YESThe question is about whether Gogoro is currently putting something it already owns or does to a different and materially more valuable use. YES The transcript shows Gogoro is already redirecting its existing battery-swapping network and smart batteries (originally built for vehicle swaps) into a new Virtual Power Plant use case via the Enel X partnership.